NCT03692182

The Use of Antipsychotics in the Program of All-inclusive Care for the Elderly (PACE)

Antipsychotic Use Within the Program of All-inclusive Care for the Elderly (PACE)

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 10,000 (actual)
• Sponsor: Tabula Rasa HealthCare · Industry
• Sex: All
• Age: 55 Years
• Healthy volunteers: Not accepted

Summary

The aim of this study is to retrospectively evaluate and describe the use of antipsychotics among participants enrolled in the Program of All-inclusive Care for the Elderly (PACE), a community-based practice setting.

Detailed description

Much national attention has been given to assessing and reducing the use of antipsychotics among nursing home residents, yet comparatively little attention has focused on antipsychotic use among older adults receiving care in community-based settings. The primary objective of this study is to determine the prevalence of antipsychotic use among a nationally representative sample of nursing home-eligible older adults in a community-based practice setting known as Program of All-inclusive Care for the Elderly (PACE). The secondary objectives are focused on characterizing antipsychotic use within PACE and for these participants. Specifically, the investigator's secondary objectives are to describe patterns of other drugs concomitantly used with antipsychotics (e.g., benzodiazepines, opioids) and to identify clinically relevant drug-drug interactions involving antipsychotics.

Conditions

• Behavioral and Psychiatric Symptoms of Dementia

Timeline

• Start date: 2017-01-01
• Primary completion: 2017-12-01
• Completion: 2019-03-01
• First posted: 2018-10-02
• Last updated: 2019-09-10

Locations

1 site across 1 country: United States